Wojcicki’s decision to step down follows months of pressure on the cofounder, whose entire board resigned on the same day last fall. For many years, Wojcicki was seen as a leading thinker, champion of consumer health rights, and one of a few women leading an influential biotech firm. Through her connections in tech, politics, and Hollywood, she helped push 23andMe and the possibilities of genetic testing into mainstream culture. But events of the last few years have raised questions about her legacy.
Here’s a timeline of events that shaped 23andMe trajectory:
Correction: This story has been updated to reflect the correct year that the FDA sent 23andMe a warning letter about its DNA tests with health risk results.
